Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 18 | 2013 | 385 | 1.760 |
Why?
|
Patient Participation | 4 | 2023 | 133 | 1.580 |
Why?
|
Colorectal Neoplasms | 9 | 2018 | 613 | 1.410 |
Why?
|
Aged | 34 | 2022 | 6095 | 1.130 |
Why?
|
Emergency Service, Hospital | 6 | 2019 | 358 | 1.040 |
Why?
|
Dental Care | 3 | 2015 | 19 | 1.010 |
Why?
|
Reminder Systems | 5 | 2013 | 80 | 1.010 |
Why?
|
Humans | 62 | 2024 | 17611 | 0.980 |
Why?
|
Electronic Health Records | 7 | 2021 | 681 | 0.950 |
Why?
|
Middle Aged | 46 | 2021 | 7911 | 0.950 |
Why?
|
Early Detection of Cancer | 6 | 2015 | 501 | 0.860 |
Why?
|
Social Isolation | 1 | 2022 | 13 | 0.850 |
Why?
|
Male | 49 | 2024 | 10008 | 0.830 |
Why?
|
Occult Blood | 5 | 2018 | 153 | 0.830 |
Why?
|
Female | 52 | 2024 | 12608 | 0.810 |
Why?
|
Medicare | 1 | 2022 | 202 | 0.770 |
Why?
|
Retrospective Studies | 19 | 2022 | 2447 | 0.700 |
Why?
|
Adult | 33 | 2023 | 7598 | 0.670 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2020 | 531 | 0.640 |
Why?
|
Immunohistochemistry | 2 | 2018 | 44 | 0.630 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 382 | 0.630 |
Why?
|
Ambulatory Care | 2 | 2019 | 244 | 0.630 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 167 | 0.590 |
Why?
|
Quality of Life | 8 | 2010 | 507 | 0.580 |
Why?
|
Primary Health Care | 4 | 2019 | 766 | 0.580 |
Why?
|
Referral and Consultation | 2 | 2020 | 167 | 0.550 |
Why?
|
Datasets as Topic | 1 | 2015 | 17 | 0.520 |
Why?
|
Preventive Health Services | 2 | 2015 | 159 | 0.490 |
Why?
|
Feces | 2 | 2014 | 80 | 0.490 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2014 | 10 | 0.480 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 1322 | 0.440 |
Why?
|
Professional-Family Relations | 1 | 2013 | 49 | 0.440 |
Why?
|
Telephone | 3 | 2012 | 161 | 0.440 |
Why?
|
Surveys and Questionnaires | 11 | 2023 | 1309 | 0.440 |
Why?
|
United States | 15 | 2022 | 3956 | 0.440 |
Why?
|
Family | 1 | 2013 | 111 | 0.430 |
Why?
|
Loneliness | 2 | 2022 | 5 | 0.420 |
Why?
|
Quality Improvement | 2 | 2015 | 189 | 0.420 |
Why?
|
Intensive Care Units | 1 | 2013 | 104 | 0.420 |
Why?
|
Logistic Models | 7 | 2019 | 926 | 0.410 |
Why?
|
Communication | 1 | 2013 | 194 | 0.400 |
Why?
|
Self Care | 3 | 2009 | 163 | 0.400 |
Why?
|
Patient Satisfaction | 4 | 2015 | 211 | 0.390 |
Why?
|
Social Determinants of Health | 2 | 2024 | 37 | 0.390 |
Why?
|
Aged, 80 and over | 10 | 2021 | 1900 | 0.380 |
Why?
|
Mass Screening | 3 | 2018 | 661 | 0.380 |
Why?
|
Chronic Disease | 6 | 2023 | 428 | 0.380 |
Why?
|
Practice Patterns, Physicians' | 4 | 2020 | 330 | 0.370 |
Why?
|
Medicaid | 3 | 2011 | 186 | 0.370 |
Why?
|
Prescription Drugs | 1 | 2010 | 31 | 0.360 |
Why?
|
Adolescent | 14 | 2015 | 3651 | 0.350 |
Why?
|
Decision Support Techniques | 3 | 2020 | 88 | 0.330 |
Why?
|
Data Collection | 5 | 2014 | 256 | 0.330 |
Why?
|
Electronic Mail | 1 | 2009 | 51 | 0.330 |
Why?
|
Health Maintenance Organizations | 6 | 2015 | 417 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 179 | 0.320 |
Why?
|
Young Adult | 5 | 2019 | 2427 | 0.320 |
Why?
|
Outcome Assessment (Health Care) | 4 | 2015 | 228 | 0.320 |
Why?
|
Continental Population Groups | 1 | 2010 | 302 | 0.310 |
Why?
|
Temporal Arteries | 1 | 2007 | 1 | 0.300 |
Why?
|
Giant Cell Arteritis | 1 | 2007 | 1 | 0.300 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2007 | 1 | 0.300 |
Why?
|
Biopsy | 1 | 2007 | 74 | 0.300 |
Why?
|
Managed Care Programs | 4 | 2012 | 325 | 0.290 |
Why?
|
Unnecessary Procedures | 2 | 2017 | 24 | 0.270 |
Why?
|
Oregon | 5 | 2013 | 171 | 0.270 |
Why?
|
Northwestern United States | 4 | 2019 | 53 | 0.250 |
Why?
|
Social Support | 1 | 2006 | 203 | 0.250 |
Why?
|
Health Services Accessibility | 4 | 2011 | 289 | 0.250 |
Why?
|
Communication Barriers | 1 | 2004 | 31 | 0.240 |
Why?
|
Postoperative Complications | 2 | 2008 | 102 | 0.240 |
Why?
|
Therapy, Computer-Assisted | 1 | 2004 | 10 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 748 | 0.230 |
Why?
|
Patient Selection | 1 | 2005 | 190 | 0.230 |
Why?
|
Renal Replacement Therapy | 2 | 2021 | 9 | 0.230 |
Why?
|
Venous Thrombosis | 1 | 2004 | 21 | 0.230 |
Why?
|
Cohort Studies | 5 | 2021 | 2570 | 0.220 |
Why?
|
Adrenal Cortex Hormones | 3 | 2010 | 68 | 0.220 |
Why?
|
Health Status | 4 | 2011 | 298 | 0.220 |
Why?
|
Child Health Services | 1 | 2004 | 113 | 0.220 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 153 | 0.220 |
Why?
|
Memory Disorders | 1 | 2022 | 7 | 0.210 |
Why?
|
Length of Stay | 2 | 2012 | 181 | 0.210 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 2002 | 3 | 0.200 |
Why?
|
Infant Welfare | 1 | 2002 | 3 | 0.200 |
Why?
|
Maternal Welfare | 1 | 2002 | 14 | 0.200 |
Why?
|
Obesity | 1 | 2008 | 837 | 0.200 |
Why?
|
Demography | 2 | 2020 | 101 | 0.200 |
Why?
|
Oral Health | 1 | 2021 | 21 | 0.190 |
Why?
|
Practice Guidelines as Topic | 4 | 2017 | 318 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2020 | 2 | 0.180 |
Why?
|
Time-to-Treatment | 1 | 2020 | 18 | 0.180 |
Why?
|
Age Factors | 3 | 2012 | 917 | 0.180 |
Why?
|
Kidney | 1 | 2020 | 52 | 0.180 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 243 | 0.180 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 12 | 0.170 |
Why?
|
Sickness Impact Profile | 3 | 2008 | 25 | 0.170 |
Why?
|
Patient Education as Topic | 2 | 2009 | 211 | 0.160 |
Why?
|
Prospective Studies | 5 | 2019 | 1267 | 0.160 |
Why?
|
Confidence Intervals | 3 | 2011 | 237 | 0.160 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 134 | 0.150 |
Why?
|
Insurance, Health | 1 | 2019 | 181 | 0.150 |
Why?
|
Central Venous Catheters | 1 | 2018 | 4 | 0.150 |
Why?
|
Hemoglobins | 1 | 2018 | 39 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2018 | 12 | 0.150 |
Why?
|
Proteinuria | 1 | 2018 | 26 | 0.150 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 487 | 0.150 |
Why?
|
Child, Preschool | 5 | 2016 | 1409 | 0.150 |
Why?
|
HIV Infections | 3 | 2000 | 694 | 0.150 |
Why?
|
Depression | 1 | 2022 | 502 | 0.150 |
Why?
|
Renal Dialysis | 1 | 2018 | 54 | 0.150 |
Why?
|
Breast Neoplasms | 2 | 2015 | 949 | 0.150 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 20 | 0.140 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 21 | 0.140 |
Why?
|
Guideline Adherence | 2 | 2015 | 155 | 0.140 |
Why?
|
Health Care Surveys | 2 | 2010 | 230 | 0.140 |
Why?
|
Patient Admission | 2 | 2012 | 72 | 0.140 |
Why?
|
Anti-Asthmatic Agents | 5 | 2013 | 85 | 0.140 |
Why?
|
Treatment Outcome | 5 | 2016 | 1259 | 0.140 |
Why?
|
Vitamin D | 1 | 2017 | 76 | 0.140 |
Why?
|
Patient-Centered Care | 3 | 2007 | 197 | 0.140 |
Why?
|
Adrenergic beta-Agonists | 2 | 2006 | 33 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 147 | 0.130 |
Why?
|
Adenoidectomy | 1 | 2016 | 1 | 0.130 |
Why?
|
Tonsillectomy | 1 | 2016 | 1 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2016 | 17 | 0.130 |
Why?
|
Clinical Protocols | 1 | 2016 | 43 | 0.130 |
Why?
|
Pain Management | 1 | 2016 | 58 | 0.130 |
Why?
|
Body Mass Index | 2 | 2012 | 958 | 0.130 |
Why?
|
Propensity Score | 1 | 2015 | 85 | 0.120 |
Why?
|
Child | 5 | 2016 | 2474 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 45 | 0.120 |
Why?
|
Patient Outcome Assessment | 1 | 2015 | 28 | 0.120 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 142 | 0.120 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 169 | 0.120 |
Why?
|
Postal Service | 1 | 2014 | 72 | 0.120 |
Why?
|
Controlled Before-After Studies | 1 | 2013 | 4 | 0.120 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 8 | 0.110 |
Why?
|
Checklist | 1 | 2013 | 15 | 0.110 |
Why?
|
Population Surveillance | 1 | 2015 | 263 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 105 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 598 | 0.110 |
Why?
|
Quality of Health Care | 2 | 2007 | 326 | 0.110 |
Why?
|
Outcome and Process Assessment (Health Care) | 1 | 2013 | 102 | 0.110 |
Why?
|
Odds Ratio | 3 | 2018 | 671 | 0.100 |
Why?
|
Time Factors | 5 | 2020 | 1086 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2013 | 72 | 0.100 |
Why?
|
Dental Prophylaxis | 1 | 2012 | 1 | 0.100 |
Why?
|
Periodontal Index | 1 | 2012 | 1 | 0.100 |
Why?
|
Periodontal Diseases | 1 | 2012 | 2 | 0.100 |
Why?
|
Perioperative Care | 1 | 2012 | 4 | 0.100 |
Why?
|
Risk Factors | 6 | 2021 | 3325 | 0.100 |
Why?
|
Pharmacists | 1 | 2012 | 48 | 0.100 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 187 | 0.100 |
Why?
|
Hypoglycemia | 1 | 2012 | 46 | 0.100 |
Why?
|
State Health Plans | 1 | 2011 | 35 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 119 | 0.090 |
Why?
|
Inpatients | 1 | 2011 | 81 | 0.090 |
Why?
|
Program Evaluation | 2 | 2015 | 223 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2004 | 844 | 0.090 |
Why?
|
Linear Models | 1 | 2010 | 231 | 0.090 |
Why?
|
Self Report | 1 | 2011 | 251 | 0.090 |
Why?
|
Sex Factors | 1 | 2012 | 643 | 0.080 |
Why?
|
Health Care Costs | 1 | 2011 | 228 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 154 | 0.080 |
Why?
|
ROC Curve | 3 | 2018 | 77 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 351 | 0.080 |
Why?
|
Medical Records Systems, Computerized | 2 | 2006 | 85 | 0.080 |
Why?
|
Health Services | 2 | 2011 | 112 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2010 | 146 | 0.080 |
Why?
|
Podiatry | 1 | 2008 | 2 | 0.080 |
Why?
|
Foot | 1 | 2008 | 3 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2012 | 1115 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2012 | 1210 | 0.080 |
Why?
|
Psychometrics | 2 | 2007 | 121 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 709 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 52 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2007 | 20 | 0.070 |
Why?
|
Infant | 2 | 2016 | 1171 | 0.070 |
Why?
|
Ethnic Groups | 1 | 2010 | 485 | 0.070 |
Why?
|
Hospitalization | 4 | 2013 | 797 | 0.070 |
Why?
|
Self Concept | 1 | 2006 | 39 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 264 | 0.070 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2006 | 10 | 0.070 |
Why?
|
Albuterol | 1 | 2006 | 7 | 0.070 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 34 | 0.070 |
Why?
|
Allergy and Immunology | 1 | 2005 | 4 | 0.070 |
Why?
|
Databases as Topic | 1 | 2005 | 19 | 0.060 |
Why?
|
Registries | 2 | 2020 | 471 | 0.060 |
Why?
|
Health Benefit Plans, Employee | 1 | 2005 | 20 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 28 | 0.060 |
Why?
|
Area Under Curve | 2 | 2018 | 33 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 630 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2013 | 381 | 0.060 |
Why?
|
Spatial Analysis | 1 | 2024 | 11 | 0.060 |
Why?
|
Language | 1 | 2004 | 51 | 0.060 |
Why?
|
Community Networks | 1 | 2024 | 24 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2015 | 325 | 0.060 |
Why?
|
Thromboembolism | 1 | 2004 | 32 | 0.060 |
Why?
|
Mammography | 2 | 2015 | 169 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2004 | 568 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2006 | 454 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2015 | 305 | 0.050 |
Why?
|
Utah | 1 | 2002 | 33 | 0.050 |
Why?
|
Perinatal Care | 1 | 2002 | 12 | 0.050 |
Why?
|
Postnatal Care | 1 | 2002 | 21 | 0.050 |
Why?
|
Minority Groups | 1 | 2022 | 101 | 0.050 |
Why?
|
Probability | 1 | 2002 | 79 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2022 | 91 | 0.050 |
Why?
|
Hospital Costs | 1 | 2002 | 39 | 0.050 |
Why?
|
Colonoscopy | 2 | 2015 | 251 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2002 | 159 | 0.050 |
Why?
|
Insurance Claim Review | 2 | 2011 | 61 | 0.050 |
Why?
|
Health Surveys | 3 | 2007 | 260 | 0.050 |
Why?
|
Anxiety | 1 | 2022 | 150 | 0.050 |
Why?
|
HIV Long-Term Survivors | 1 | 2000 | 2 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 34 | 0.040 |
Why?
|
Patient Discharge | 1 | 2002 | 154 | 0.040 |
Why?
|
Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 2 | 0.040 |
Why?
|
Patient Readmission | 1 | 2002 | 163 | 0.040 |
Why?
|
Urban Health Services | 1 | 1998 | 11 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 606 | 0.040 |
Why?
|
Los Angeles | 1 | 1998 | 139 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2021 | 415 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 304 | 0.040 |
Why?
|
California | 3 | 2015 | 2284 | 0.040 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 53 | 0.040 |
Why?
|
Health Status Indicators | 2 | 2008 | 64 | 0.030 |
Why?
|
Pregnancy | 1 | 2002 | 1494 | 0.030 |
Why?
|
Codeine | 1 | 2016 | 2 | 0.030 |
Why?
|
Community Health Services | 1 | 1996 | 83 | 0.030 |
Why?
|
Group Practice | 1 | 2016 | 25 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2015 | 9 | 0.030 |
Why?
|
Mid-Atlantic Region | 1 | 2015 | 9 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 51 | 0.030 |
Why?
|
Risk Assessment | 1 | 2020 | 1097 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2015 | 48 | 0.030 |
Why?
|
Medical Records | 1 | 2015 | 100 | 0.030 |
Why?
|
Program Development | 1 | 2015 | 69 | 0.030 |
Why?
|
Survivors | 1 | 2015 | 149 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 205 | 0.030 |
Why?
|
Databases, Factual | 2 | 2006 | 309 | 0.030 |
Why?
|
Qualitative Research | 1 | 2015 | 254 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2013 | 20 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2015 | 201 | 0.030 |
Why?
|
Professional Role | 1 | 2012 | 10 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2012 | 16 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 250 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2011 | 85 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2013 | 710 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 322 | 0.020 |
Why?
|
Patient Care Team | 1 | 2012 | 113 | 0.020 |
Why?
|
Risk | 1 | 2011 | 516 | 0.020 |
Why?
|
Blood Glucose | 1 | 2012 | 341 | 0.020 |
Why?
|
Self Efficacy | 1 | 2009 | 68 | 0.020 |
Why?
|
Colorado | 1 | 2007 | 163 | 0.020 |
Why?
|
Administration, Oral | 1 | 2007 | 85 | 0.020 |
Why?
|
Pilot Projects | 1 | 2008 | 218 | 0.020 |
Why?
|
Pacific States | 1 | 2006 | 4 | 0.020 |
Why?
|
Drug Utilization | 1 | 2007 | 127 | 0.020 |
Why?
|
Specialization | 1 | 2005 | 24 | 0.020 |
Why?
|
Pulmonary Medicine | 1 | 2005 | 19 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2005 | 35 | 0.020 |
Why?
|
Emotions | 1 | 2005 | 34 | 0.020 |
Why?
|
Comorbidity | 1 | 2007 | 594 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2005 | 116 | 0.010 |
Why?
|
Self Disclosure | 1 | 1996 | 22 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1996 | 178 | 0.010 |
Why?
|